Global Jet Lag Treatment Market Size, Status and Forecast 2021-2027

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.

The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.

In our report, the measurement level is unit, which means that each unit is the same as each pill.
North America is the largest consumption place, with a consumption market share nearly 42.36% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23.16%.

Market Analysis and Insights: Global Jet Lag Treatment Market
The global Jet Lag Treatment market size is projected to reach US$ 544.5 million by 2027, from US$ 408.3 million in 2020, at a CAGR of 4.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Jet Lag Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Jet Lag Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Jet Lag Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Jet Lag Treatment market.

Global Jet Lag Treatment Scope and Market Size
Jet Lag Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Jet Lag Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription
OTC
Prescription Drugs have the largest market share segment, with 63%, and OTC is the fastest-growing category

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online
Retail Pharmacies had the largest market share of 58 per cent, with Online the fastest growing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma